Medfinder
Expert medication guides

The Found Script

Go beyond finding medications. Expert guides, shortage updates, and tips for navigating the healthcare system.

2379 articles in Drug ShortagesClear all filters
Why is Eohilia so hard to find? [Explained for 2026]
Drug Shortages

Why is Eohilia so hard to find? [Explained for 2026]

Eohilia is hard to find due to specialty pharmacy distribution, insurance barriers, and limited availability. Learn why and what you can do about it.

By Peter Daggett·
Amoxicillin/Clavulanate Shortage: What Providers and Prescribers Need to Know in 2026
For Healthcare ProvidersDrug Shortages

Amoxicillin/Clavulanate Shortage: What Providers and Prescribers Need to Know in 2026

A provider-focused briefing on the Amoxicillin/Clavulanate shortage in 2026: timeline, prescribing implications, alternatives, and tools to help patients.

By Peter Daggett·
Why Is Nitrofurantoin So Hard to Find? [Explained for 2026]
Drug Shortages

Why Is Nitrofurantoin So Hard to Find? [Explained for 2026]

Having trouble finding Nitrofurantoin at your pharmacy? Learn why this common UTI antibiotic is hard to find in 2026 and what you can do about it.

By Peter Daggett·
Nitrofurantoin Shortage Update: What Patients Need to Know in 2026
Drug Shortages

Nitrofurantoin Shortage Update: What Patients Need to Know in 2026

Is Nitrofurantoin still in shortage in 2026? Get the latest update on availability, pricing, and what to do if you can't find your UTI medication.

By Peter Daggett·

29,000+ have already found their meds with Medfinder.

Stop calling pharmacies. Start your search today.

Why Is Ozempic So Hard to Find? [Explained for 2026]
Drug Shortages

Why Is Ozempic So Hard to Find? [Explained for 2026]

Find out why Ozempic has been so hard to find, what caused the shortage, and what you can do in 2026 to get your prescription filled.

By Peter Daggett·
Why Is Adalimumab So Hard to Find? [Explained for 2026]
Drug Shortages

Why Is Adalimumab So Hard to Find? [Explained for 2026]

Struggling to find adalimumab (Humira) at your pharmacy? Learn why this biologic medication can be hard to locate and what you can do about it in 2026.

By Peter Daggett·
Why Is Aurovela Fe 1/20 So Hard to Find? [Explained for 2026]
Drug Shortages

Why Is Aurovela Fe 1/20 So Hard to Find? [Explained for 2026]

Struggling to find Aurovela Fe 1/20 at your pharmacy? Learn why this birth control pill is hard to find in 2026 and what you can do about it.

By Peter Daggett·
Why Is Onexton So Hard to Find? [Explained for 2026]
Drug Shortages

Why Is Onexton So Hard to Find? [Explained for 2026]

Struggling to find Onexton at your pharmacy? Learn why this acne gel is so hard to find in 2026 and what you can do to get your prescription filled.

By Peter Daggett·
Why Is Prempro 0.45/1.5 28 Day So Hard to Find? [Explained for 2026]
Drug Shortages

Why Is Prempro 0.45/1.5 28 Day So Hard to Find? [Explained for 2026]

Struggling to find Prempro 0.45/1.5 28 Day at your pharmacy? Learn why this menopause medication is so hard to find in 2026 and what you can do about it.

By Peter Daggett·
Prempro 0.45/1.5 28 Day Shortage: What Providers and Prescribers Need to Know in 2026
For Healthcare ProvidersDrug Shortages

Prempro 0.45/1.5 28 Day Shortage: What Providers and Prescribers Need to Know in 2026

A provider-focused briefing on Prempro 0.45/1.5 28 Day availability in 2026: supply status, prescribing implications, alternatives, cost considerations, and tools.

By Peter Daggett·
Why Is Estrogens, Esterified So Hard to Find? [Explained for 2026]
Drug Shortages

Why Is Estrogens, Esterified So Hard to Find? [Explained for 2026]

Find out why Estrogens, Esterified (Menest) is so hard to find in 2026. We explain the shortage causes, supply chain issues, and what you can do right now.

By Peter Daggett·
Entresto Shortage: What Providers and Prescribers Need to Know in 2026
For Healthcare ProvidersDrug Shortages

Entresto Shortage: What Providers and Prescribers Need to Know in 2026

A clinical briefing for providers on Entresto availability in 2026 — covering the generic transition, Medicare pricing, prescribing implications, and patient access tools.

By Peter Daggett·
PreviousPage 48 of 199Next